Filing Flows › Comparisons › ABEO vs LXRX
Abeona Therapeutics vs Lexicon Pharmaceuticals: ABEO and LXRX compared
Abeona Therapeutics is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $11.2M for Lexicon Pharmaceuticals (Q3 2026). Abeona Therapeutics is growing faster (28× against -21% a year earlier). Abeona Therapeutics is more profitable, with an operating margin of -120.0% against -128.8%.
Where the money goes: ABEO and LXRX
Abeona Therapeutics (ABEO) · Q2 2026
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
Lexicon Pharmaceuticals (LXRX) · Q3 2026
Lexicon Pharmaceuticals, Q3 2026: revenue $11.2M (-21% year over year), operating margin -128.8%, net loss $14.0M, operating cash flow −$8.1M. The chart follows the revenue to costs, profit and cash.
| Abeona Therapeutics (ABEO) | Lexicon Pharmaceuticals (LXRX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $11.4M | $11.2M |
| Revenue growth, Y/Y | 28× | -21% |
| Operating margin | -120.0% | -128.8% |
| Net earnings | −$20.2M | −$14.0M |
| Net margin | -177.4% | -124.5% |
| Operating cash flow | −$17.5M | −$8.1M |
Questions
Which is bigger, Abeona Therapeutics or Lexicon Pharmaceuticals?
Abeona Therapeutics is the larger company: $11.4M of revenue in its latest quarter (Q2 2026) against $11.2M for Lexicon Pharmaceuticals (Q3 2026).
Is Abeona Therapeutics or Lexicon Pharmaceuticals growing faster?
Abeona Therapeutics is growing faster (28× against -21% a year earlier).
Which is more profitable, Abeona Therapeutics or Lexicon Pharmaceuticals?
Abeona Therapeutics is more profitable, with an operating margin of -120.0% against -128.8%.
More: Abeona Therapeutics earnings · how Abeona Therapeutics makes money · Lexicon Pharmaceuticals earnings · how Lexicon Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.